Products for Research Use Only
RegisterLogin

Davoceticept

CAT: 0804-HY-P99844-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99844-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Davoceticept (ALPN-202; CD80 vIgD-Fc) is a variant CD80 vIgD-Fc fusion protein targeting CTLA-4 and PD-L1. Davoceticept consists of the (1-107) fragment of CD80 linked to IGHG1 Fc via a peptidyl linker. The expression system of Davoceticept is usually CHO (Chinese Hamster Ovary) cells[1].
CAS Number
2307144-64-3
Product Name Alternative
ALPN-202; CD80 vIgD-Fc
UNSPSC
12352203
Target
CTLA-4
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/davoceticept.html
Purity
99.96
Solubility
10 mM in DMSO
Smiles
[Davoceticept]
Molecular Weight
(77.425 kDa)
References & Citations
[1]Davoceticept. IMGT.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
T80598-01Davoceticept
GTR18334124-01Davoceticept Antibody
DHJ70122Research Grade Davoceticept
E55B1156Davoceticept (Reference antibody)
GTR18696812-01Davoceticept Monoclonal Antibody
ICH5467-5mgDavoceticept Biosimilar - Research Grade
PX-TA2009-01Davoceticept Biosimilar - Anti-CTLA-4, PD-L1, CD28 fusion protein - Research Grade
A135998Davoceticept Biosimilar (, Fusion - [CD80 (B7-1, CD28LG1) fragment (1-107) ]2 - IGHG1 Fc (Fragment constant) )

Popular Products